Expression of growth factors and their receptors in neuropathic ulcerative defects of patients diagnosed with diabetes in a South American cohort.

21 October 2023, Version 1
This content is an early or alternative research output and has not been peer-reviewed by Cambridge University Press at the time of posting.

Abstract

Objective. The aim of the study is carrying out a comparative analysis of the expression of RFs and their receptors in non-healing chronic ulcer defects of different duration in diabetic foot syndrome in a South American cohort. Methods. Immunohistochemical analysis of biopsy samples was performed using antibodies against the following risk factors and their receptors: vascular endothelial factor (VEGF), insulin-like factor (IGF), epidermal factor (EGF). Depending on the duration of the wound, the biopsies were divided into 3 groups. Results. In wound samples whose duration did not exceed 90 days, the expression of FCs and their receptors was significantly higher than in wounds of longer duration (p = 0.0001). There were no significant differences in the quantitative indicators of the expression of FCs and their receptors between wounds that lasted from 91 to 365 days and more than 365 days. Conclusion. In ulcerative defects in the neuropathic form of diabetic foot syndrome that last ≤90 days, the expression of factors such as VEGF, IGF, EGF and their receptors is statistically significantly higher than in wounds of longer duration.

Keywords

diabetic foot syndrome
non-healing ulcers
growth factors
vascular endothelial growth factor
insulin-like growth factor
epidermal growth factor

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting and Discussion Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.